UCB

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch UCB and buy or sell other stocks, ETFs, and their options commission-free!

About UCBJY

UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. 

CEO
Jean-Christophe Tellier
CEOJean-Christophe Tellier
Employees
10,117
Employees10,117
Headquarters
Brussels, Brussels Region
HeadquartersBrussels, Brussels Region
Founded
1925
Founded1925
Employees
10,117
Employees10,117

UCBJY Key Statistics

Market cap
56.27B
Market cap56.27B
Price-Earnings ratio
31.41
Price-Earnings ratio31.41
Dividend yield
0.33%
Dividend yield0.33%
Average volume
38.95K
Average volume38.95K
High today
High today
Low today
Low today
Open price
$145.46
Open price$145.46
Volume
0.00
Volume0.00
52 Week high
$168.76
52 Week high$168.76
52 Week low
$71.16
52 Week low$71.16

Analyst ratings

77%

of 22 ratings
Buy
77.3%
Hold
13.6%
Sell
9.1%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.